Brian Kelly Hunt, MD in Folsom, CA - Medicare Pain Management

Brian Kelly Hunt, MD is a medicare enrolled "Pain Medicine - Interventional Pain Medicine" physician in Folsom, California. He went to Eastern Virginia Medical School and graduated in 1996 and has 28 years of diverse experience with area of expertise as Pain Management. He is a member of the group practice Hendrickson And Hunt Pain Management Physicians, A Corp and his current practice location is 2350 East Bidwell St, Folsom, California. You can reach out to his office (for appointments etc.) via phone at (916) 984-3899.

Brian Kelly Hunt is licensed to practice in California (license number A63152) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1821042573.

Contact Information

	Brian Kelly Hunt, MD
	2350 East Bidwell St, Folsom, CA 95630-3455
	(916) 984-3899
	(916) 984-6522

Physician's Profile

Full Name	Brian Kelly Hunt
Gender	Male
Speciality	Pain Management
Experience	28 Years
Location	2350 East Bidwell St, Folsom, California
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Brian Kelly Hunt attended and graduated from Eastern Virginia Medical School in 1996

NPI Data:

NPI Number: 1821042573
Provider Enumeration Date: 05/19/2006
Last Update Date: 11/19/2015

Medicare PECOS Information:

PECOS PAC ID: 1052359924
Enrollment ID: I20050420001395

Medical Identifiers

Medical identifiers for Brian Kelly Hunt such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1821042573	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208VP0014X	Pain Medicine - Interventional Pain Medicine	A63152 (California)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Hendrickson And Hunt Pain Management Physicians, A Corp	6507874245	2

News Archive

New computational method quickly predicts three-dimensional structure of protein

An Oak Ridge National Laboratory invention able to quickly predict three-dimensional structure of protein could have huge implications for drug discovery and human health.

Newron Pharmaceuticals submits safinamide NDA to FDA

Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA).

US FDA cracks down on importation of unapproved new drugs for personal use

The United States Food and Drug Administration ("FDA") is cracking down on the importation of unapproved new drugs with regards to personal use. Import Alert #66-41, "Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S." ("IA 66-41") was most recently published on September 23, 2010. IA 66-41 contains a Red List, a list of importers whose products are automatically detained for FDA violations, of over 400 firms on the charge of importing misbranded unapproved new drugs. Benjamin England, founder of FDAImports.com, LLC and former FDA Compliance Officer, attorney, and Food and Drug Law expert states that "This Import Alert has been expanded to include importers and products of drugs imported strictly for personal use rather than just targeting foreign shippers, which is FDA's normal M.O."

Clementia expands enrollment to include children with FOP in ongoing Phase 2 clinical trial

Clementia Pharmaceuticals, Inc. today announced the initiation of enrollment of children as young as 6 years old in the company's ongoing Phase 2 study of palovarotene for the treatment of fibrodysplasia ossificans progressiva (FOP).

FDA panel to review Cameron Health S-ICD System PMA application

Cameron Health, Inc. announced today that the U.S. Food and Drug Administration Circulatory System Devices Panel will review the Premarket Approval (PMA) application of the S-ICD System on April 26, 2012.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Brian Kelly Hunt allows following entities to bill medicare on his behalf.

Entity Name	Hendrickson & Hunt Pain Management Physicians, A Corp
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1013966407 PECOS PAC ID: 6507874245 Enrollment ID: O20060322000593

News Archive

New computational method quickly predicts three-dimensional structure of protein

An Oak Ridge National Laboratory invention able to quickly predict three-dimensional structure of protein could have huge implications for drug discovery and human health.

Newron Pharmaceuticals submits safinamide NDA to FDA

US FDA cracks down on importation of unapproved new drugs for personal use

Clementia expands enrollment to include children with FOP in ongoing Phase 2 clinical trial

FDA panel to review Cameron Health S-ICD System PMA application

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Brian Kelly Hunt is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Brian Kelly Hunt, MD 2350 East Bidwell St, Folsom, CA 95630 Ph: (916) 984-3899	Brian Kelly Hunt, MD 2350 East Bidwell St, Folsom, CA 95630-3455 Ph: (916) 984-3899

News Archive

New computational method quickly predicts three-dimensional structure of protein

An Oak Ridge National Laboratory invention able to quickly predict three-dimensional structure of protein could have huge implications for drug discovery and human health.

Brian Kelly Hunt, MD - Medicare Pain Management in Folsom, CA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

New computational method quickly predicts three-dimensional structure of protein

Newron Pharmaceuticals submits safinamide NDA to FDA

US FDA cracks down on importation of unapproved new drugs for personal use

Clementia expands enrollment to include children with FOP in ongoing Phase 2 clinical trial

FDA panel to review Cameron Health S-ICD System PMA application

Medicare Reassignments

New computational method quickly predicts three-dimensional structure of protein

Newron Pharmaceuticals submits safinamide NDA to FDA

US FDA cracks down on importation of unapproved new drugs for personal use

Clementia expands enrollment to include children with FOP in ongoing Phase 2 clinical trial

FDA panel to review Cameron Health S-ICD System PMA application

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

New computational method quickly predicts three-dimensional structure of protein

Newron Pharmaceuticals submits safinamide NDA to FDA

US FDA cracks down on importation of unapproved new drugs for personal use

Clementia expands enrollment to include children with FOP in ongoing Phase 2 clinical trial

FDA panel to review Cameron Health S-ICD System PMA application

Pain Medicine Doctors in Folsom, CA